Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Sequelae in Childhood Leukemia Survivors Assessed

Cancer; ePub 2017 Nov 3; Goldsby, Stratton, et al

Leukemia survivors with Down syndrome appear to have the same types of treatment-related chronic health issues as those without the condition, but there are a few notable exceptions, researchers concluded after conducting a study involving 735 individuals. Participants from the Childhood Cancer Survivor Study included survivors of pediatric leukemia either with (n=154) or without (n=581) Down syndrome. Investigators assessed answers to chronic health condition questionnaires.

The risk of having at least 1 late onset chronic condition was the same in both contingents. However, survivors of Down syndrome were:

  • 70% more likely to experience serious chronic conditions.
  • More apt to have cataracts, hearing loss, and thyroid dysfunction.
  • Less likely to have second cancers.

25-year cumulative incidence of any condition was 83% in Down syndrome survivors, vs 69% in those without the condition.

Citation:

Goldsby R, Stratton K, Raber S, et al. Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report. [Published online ahead of print November 3, 2017]. Cancer. doi:10.1002/cncr.31065.

Must Reads in Leukemia, Myelodysplasia, Transplantation

CAR T induced resistance in ALL, Ruella M et al. Nat Med. 2018 Oct 1. doi: 10.1038/s41591-018-0201-9

Cochrane on Bisphosphonates in Multiple Myeloma, Cochrane; 2017 Dec 18; Mhaskar, Kumar, et al

Venetoclax Regimens Assessed in Patients with AML, Am J Hematol; ePub 2017 Dec 23; DiNardo, et al

Encourage This Behavior in Childhood ALL Survivors, Cancer; ePub 2017 Dec 4; Howell, Wilson, et al

Prognostic Testing Patterns, CLL Outcomes Assessed, Clin Lymphoma Myeloma Leuk; ePub 2017 Dec 5; Mato, et al